Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients.
about
The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial.No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trialEstimation of Mycophenolic Acid Area Under the Curve With Limited-Sampling Strategy in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium.How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.Therapeutic drug monitoring of mycophenolate in adult solid organ transplant patients: an update.Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failure.Outcomes of standard dose EC-MPS with low exposure to CsA in DCD renal transplantation recipients with DGF.Enteric-coated mycophenolate sodium.Lower dosing of enteric-coated mycophenolate sodium (Myfortic) can achieve target mycophenolic acid exposure rapidly in most Chinese renal transplant patients: a pilot study.Which is more suitable for kidney transplantation at the early post-transplantation phase in China - low dosing or standard dosing of enteric-coated mycophenolate sodium?High interpatient variability in response to mycophenolic acid maintenance therapy in patients with ANCA-associated vasculitis.Cyclosporine A and tacrolimus combined with enteric-coated mycophenolate sodium influence the plasma mycophenolic acid concentration - a randomised controlled trial in Chinese live related donor kidney transplant recipients.
P2860
Q34995106-83A904E5-A7FE-4759-90C7-3A5E7159E4FDQ36243648-FE53C9FF-93F3-471F-890D-9E8612CA8713Q37086991-06D6334B-7054-41DD-AF3A-D33CFF586EB4Q37582505-0428AF4F-0405-4DC2-AB7F-9C46B4688A0FQ38170321-B6FE36D0-E064-4C8C-A48A-3A3133836579Q38208983-4B460A4E-AF8A-4753-A87C-70D2573C6569Q38791599-0F2677CB-5EF1-4F77-8FE4-5197BBC805A0Q39016704-0930DD4D-9291-4357-8B7D-24CCECCB88C9Q41584990-A741FF5C-AAC6-4B3B-A67C-09D929176C4BQ42925114-195319B8-575E-4F6E-A451-6EDE215AF99DQ45778554-ACF97069-A256-4E5D-8207-E74B708A33DFQ51745633-15750682-C053-4D69-A4EB-6759AEF0CAAFQ53566637-8874B3D2-23F1-46B2-B8AB-0DF4F02BFEC8Q53791202-069D9C3F-2C84-4B28-B1B4-98CCEF6424FE
P2860
Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacokinetic and pharmacody ...... in renal transplant patients.
@ast
Pharmacokinetic and pharmacody ...... in renal transplant patients.
@en
type
label
Pharmacokinetic and pharmacody ...... in renal transplant patients.
@ast
Pharmacokinetic and pharmacody ...... in renal transplant patients.
@en
prefLabel
Pharmacokinetic and pharmacody ...... in renal transplant patients.
@ast
Pharmacokinetic and pharmacody ...... in renal transplant patients.
@en
P2093
P2860
P50
P1476
Pharmacokinetic and pharmacody ...... e in renal transplant patients
@en
P2093
Claudia Sommerer
Martin Zeier
Petra Glander
Sandra Müller-Krebs
Vedat Schwenger
P2860
P304
P356
10.1111/J.1365-2125.2009.03612.X
P407
P577
2010-04-01T00:00:00Z